Sutro Biopharma to Collaborate With Memorial Sloan-Kettering Cancer Center to ... PR Newswire (press release) SAN FRANCISCO, Jan. 7, 2014 /PRNewswire/ -- Sutro Biopharma, a biopharmaceutical company developing a new generation of protein therapeutics, including next-generation antibody drug conjugates and bispecific antibodies, today announced that it has ... Memorial Sloan-Kettering to Use Sutro Technology for Neuroblastoma Research |
